^
    over1year
    Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=148, Not yet recruiting, Qilu Pharmaceutical Co., Ltd.
    New P1 trial • Metastases
    |
    QLS1103